Immix Biopharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q2 2024 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q3 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
Immix Biopharma, Inc. Earnings Date And Information
Immix Biopharma, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.21 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Immix Biopharma, Inc. has generated $-1 earnings per share over the last year ($-0.89 diluted earnings per share) and currently has a price-to-earnings ratio of -2.26. Immix Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Immix Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.24 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.21 | -$0.15 | 0.06 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.23 | -$0.22 | 0.01 | $0 | |
| 03/29/2024 | Q4 2023 | -$0.23 | -$0.26 | -0.03 | $4,784 | |
| 11/09/2023 | Q3 2023 | -$0.23 | $0 | |||
| 08/11/2023 | Q2 2023 | -$0.17 | -$0.24 | -0.07 | $0 | |
| 05/12/2023 | Q1 2023 | -$0.14 | -$0.18 | -0.04 | $0 | |
| 03/27/2023 | Q4 2022 | $0.22 | -$0.29 | -0.51 | $-89,517,000 | |
| 11/09/2022 | Q3 2022 | -$0.11 | $0 | |||
| 08/12/2022 | Q2 2022 | -$0.11 | $0 | |||
| 05/13/2022 | Q1 2022 | -$0.10 | $0 | |||
| 03/28/2022 | Q4 2021 | -$3.00 | $0 | |||
| 09/29/2021 | Q3 2021 | -$0.06 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.02 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.12 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.10 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.02 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.04 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.04 | $0 |
Immix Biopharma, Inc. Earnings: Frequently Asked Questions
-
When is Immix Biopharma, Inc.'s earnings date?
Immix Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did Immix Biopharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Immix Biopharma, Inc. (:IMMX) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.21 by $0.06.
-
How can I listen to Immix Biopharma, Inc.'s earnings conference call?
The conference call for Immix Biopharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Immix Biopharma, Inc.'s conference call transcript?
The conference call transcript for Immix Biopharma, Inc.'s latest earnings report can be read online.
-
How much profit does Immix Biopharma, Inc. generate each year?
Immix Biopharma, Inc. (:IMMX) has a recorded net income of $0. Immix Biopharma, Inc. has generated $-0.89 earnings per share over the last four quarters.
-
What is Immix Biopharma, Inc.'s price-to-earnings ratio?
Immix Biopharma, Inc. (:IMMX) has a price-to-earnings ratio of -2.26 and price/earnings-to-growth ratio is 1.94.
